share_log

Raymond James Initiates Coverage On Aquestive Therapeutics With Outperform Rating, Announces Price Target of $7

Moomoo 24/7 ·  Mar 28 07:10

Raymond James analyst Gary Nachman initiates coverage on Aquestive Therapeutics (NASDAQ:AQST) with a Outperform rating and announces Price Target of $7.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment